Found: 5
Select item for more details and to access through your institution.
AAV-Vectored Expression of Marburg Virus–Neutralizing Antibody MR191 Provides Complete Protection From Challenge in a Guinea Pig Model.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S682, doi. 10.1093/infdis/jiad345
- By:
- Publication type:
- Article
Analysis of the impact of pluronic acid on the thermal stability and infectivity of AAV6.2FF.
- Published in:
- BMC Biotechnology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12896-024-00853-6
- By:
- Publication type:
- Article
Overcoming Barriers to Preventing and Treating P. aeruginosa Infections Using AAV Vectored Immunoprophylaxis.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3162, doi. 10.3390/biomedicines10123162
- By:
- Publication type:
- Article
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 362, doi. 10.3390/biomedicines10020362
- By:
- Publication type:
- Article
Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models.
- Published in:
- Biomedicines, 2021, v. 9, n. 9, p. 1186, doi. 10.3390/biomedicines9091186
- By:
- Publication type:
- Article